Zotarolimus-Eluting Stents

This chapter reviews the technological iterations of zotarolimus-eluting stents (ZES) for the treatment of coronary artery disease, with a focus on its pivotal features, clinical efficacy and safety data. Performance of ZES is discussed in detail in a broad spectrum of patients and clinical settings, including challenging scenarios such as left main stem, small coronary vessels, high-bleeding risk and diabetic patients. As summarized in this chapter, a large amount of observational and randomized data supports the performance of ZES, which is comparable to other contemporary drug-eluting stents.